Trials / Unknown
UnknownNCT03826485
Safety, Pharmacokinetic Study of PRIC in Healthy Adult Subjects
A Randomized, Open-label, Single-dose, Crossover Study to Compare Pharmacokinetics of PRIC and Pranlukast Dry Syrup in Healthy Male Volunteers
- Status
- Unknown
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 48 (estimated)
- Sponsor
- SamA Pharmaceutical Co., Ltd · Industry
- Sex
- Male
- Age
- 19 Years – 40 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is Safety, Pharmacokinetic Study of PRIC
Detailed description
1. To Compare Pharmacokinetics of PRIC and Pranlukast Dry Syrup 2. To evaluate the safety and tolerability of PRIC and Pranlukast Dry Syrup
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | PRIC | Pranlukast hydrate 50mg |
| DRUG | Pranlukast hydrate | Pranlukast hydrate 225mg/2.25g |
Timeline
- Start date
- 2019-04-01
- Primary completion
- 2019-04-25
- Completion
- 2019-07-31
- First posted
- 2019-02-01
- Last updated
- 2019-02-01
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT03826485. Inclusion in this directory is not an endorsement.